Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03867552
Other study ID # 19.08/Gynaeco19.01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2019
Est. completion date February 17, 2022

Study information

Verified date March 2022
Source Jessa Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pain relief after laparoscopic surgery with the use of an altered gas.


Description:

Pain after laparoscopic surgery remains an important concern in the treatment of endometriosis or other gynaecologic laparoscopic surgery. Several trials have demonstrated that the use of an altered insufflation gas (10 % nitrous oxide + 4% oxygen + 86% carbon dioxide) reduces pain. It also decreases inflammation and adhesion formation as a surplus. With this mono-center, investigator initiated, double-blinded, randomized controlled superiority trial, the investigators want to demonstrate a reduced postoperative pain and peritoneal inflammatory reaction following peritoneal conditioning with an altered insufflation gas compared to the standard carbon dioxide (100% CO2) insufflation gas. Therefore, women undergoing laparoscopic (gynaecological) surgery with an estimated surgical time of >60 minutes will be asked to participate in this trial. Baseline characteristics will be assessed, including the patients' age, body mass index, medial history, American Society of Anesthesiologist Classification (ASA classification), work status, highest level of education, fear for the surgical procedure (using an 8-item surgical fear questionnaire), pre-operative pain (using a Numerical Rating Scale (NRS) were 0= no pain and 10= worst pain imaginable) both in resting position and in an active position), expected pain (NRS), baseline quality of recovery (QOR) (using the 1-item Global Surgical Recovery (GSR) index (3) and the Functional Recovery Index (FRI) (4)) as well as baseline quality of Life (QOL), using the 5-dimensional European Quality of Life (EQ-5D) questionnaire.


Recruitment information / eligibility

Status Completed
Enrollment 74
Est. completion date February 17, 2022
Est. primary completion date February 17, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Woman = 18 years old - undergoing laparoscopic surgery for endometriosis, uterine myoma's, hysterectomy or colpopexy. Exclusion Criteria: - Women < 18 years old - Males - Pregnancy - Conditions associated with chronic pain, such as peripheral neuropathy, pathology of the vertebral column and osteo-articular disease. - Conditions causing acute pain e.g. abdominal trauma

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Altered gas (86% CO2, 10% N2O, 4% O2)
Assessment of pain degree after laparoscopic surgery with the altered gas (86% CO2, 10% N2O, 4% O2)
Standardized gas (100% CO2)
Assessement of pain degree after laparoscopic surgery with the standardized gas (100% CO2)

Locations

Country Name City State
Belgium Jessa Hospital Hasselt Limburg

Sponsors (1)

Lead Sponsor Collaborator
Jessa Hospital

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of post-operative pain with an 11-point numerical rating score (NRS) Assessement of pain after laparoscopic surgery with the use of the altered gas compared to standard gas with NRS, where 0 means no pain and 10 means worst imaginable pain 4 hours after laparoscopic surgery
Secondary Assessment of post-operative pain (NRS) Assessement of pain at different time points after surgery with an 11-point numerical rating score NRS, where 0 means no pain and 10 means worst imaginable pain 8 hours, 24 hours and 7 days after laparoscopic surgery
Secondary Nausea Assessment of nausea at different time points after surgery (yes/no) 4 hours, 8 hours, 24 hours and 7 days after laparoscopic surgery
Secondary Post-operative use of piritramide (Dipidolor®) Dose of piritramide after laparoscopic surgery in patients treated with altered gas compared to patients treated with the standard gas Up to 24 hours after laparoscopic surgery
Secondary Assessment of degree of a possible inflammatory reaction Assessed via standard medical practice: body temperature will be measured in °C in order to investigate fever Through study completion, up to 7 days after laparoscopic surgery
Secondary Assessment of degree of a possible inflammatory reaction Assessed via standard medical practice: potential blood samples measuring C-Reactive Protein (in mg/l) which is a measure for inflammation can be measured if needed throughout the study Through study completion, up to 7 days after laparoscopic surgery
Secondary Time to resumption of transit Time to first flatus and time to first stool Through study completion, up to 7 days after laparoscopic surgery
Secondary Assessment of quality of Recovery (QOR) Assessment of QOR using the 1-item Global Surgical Recovery (GSR) index which represents a single question about the extent to which patients considered themselves to be recovered from surgery ("if 100% recovery means the participants health is back to the same level as it was before the surgery, what percentage of recovery is the participant at now") 24 hours and 7 days after laparoscopic surgery
Secondary Assessment of quality of Recovery (QOR) Assessment of QOR using the Functional Recovery Index (FRI) questionnaire which assesses functional QOL on an NRS scale and covers 14 items grouped under three factors (pain and social activity, lower limb activity and general physical activity) 24 hours and 7 days after laparoscopic surgery
Secondary Patient satisfaction Assessement of patient satisfaction via a seven-point Likert scale, where 1 means extremely unsatisfied and 7 means extremely satisfied 7 days after laparoscopic surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies N/A
Enrolling by invitation NCT05534490 - Surgery and Functionality in Older Adults N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Terminated NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Recruiting NCT06397287 - PROM Project Urology
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03432429 - Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT04602429 - Children's Acute Surgical Abdomen Programme
Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
Completed NCT04595695 - The Effect of Clear Masks in Improving Patient Relationships N/A
Recruiting NCT06103136 - Maestro 1.0 Post-Market Registry
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A